Seroprevalence of SARS-CoV-2 in Brazil: A systematic review and meta-analysis

Imagem de Miniatura
Arquivos
art_FIGUEIREDO_Seroprevalence_of_SARSCoV2_in_Brazil_A_systematic_review_2023.PDF (941.59 KB)
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER ESPANA
Autores
Citação
CLINICS, v.78, article ID 100233, 8p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: To summarize the data on SARS-CoV-2 seroprevalence surveys conducted in Brazil before the introduction of vaccines Methods: The authors conducted a systematic review and meta-analysis on the seroprevalence of SARS-CoV-2 infection in Brazil. The present review followed the PRISMA guidelines. The authors searched Medline, Embase, and LILACS databases for serologic surveys conducted in the Brazilian population, in the period from 01/10/ 2019 to 07/11/2021, without language restrictions. The authors included studies that presented data concerning SARS-CoV-2 antibodies seroprevalence in Brazil and had a sample size & GE;50 individuals. Considering the expected heterogeneity between studies, all analyses were performed using the random effects model, and heterogeneity was assessed using the I2 statisticResults: Of 586 publications identified in the initial searches, 54 were included in the review and meta-analysis, which contained the results of 135 surveys, with 336,620 participants. The estimated seroprevalence was 11.0%, ranging from 1.0% to 83.0%, with a substantial heterogeneity (I2 = 99.55%). In subgroup analyses, the authors observed that the prevalence of SARS-CoV-2 antibodies was 13.0% in blood donors, 9.0% in the population-based surveys, 13% in schoolchildren, and 11.0% in healthcare workers.Conclusions: Seroprevalence increases over time. Large differences were observed among the regions of the country. It was higher in the Northern region, decreasing towards the South. The present results may contribute to the analysis of the spread of SARS-CoV-2 infection in the Brazilian population before vaccination, one of the factors that may be influencing the clinical presentation of COVID-19 cases related to the new variants, as well as the effectiveness of the vaccination program.
Palavras-chave
Seroprevalence, SARS-CoV-2, Systematic review, Meta-analysis
URI
https://observatorio.fm.usp.br/handle/OPI/54770
Referências
  1. Albuquerque JOM, 2021, REV SAUDE PUBL, V55, P62, DOI 10.11606/S1518-8787.2021055003970
  2. Amorim L, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054002643
  3. Appak O, 2021, IRAN J MICROBIOL, V13, P565, DOI 10.18502/ijm.v13i5.7417
  4. Bajema KL, 2021, JAMA INTERN MED, V181, P450, DOI 10.1001/jamainternmed.2020.7976
  5. BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
  6. Bernardes-Souza B, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/30406
  7. Borges LP, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.108
  8. Buss LF, 2021, SCIENCE, V371, P288, DOI 10.1126/science.abe9728
  9. Calife K., 2020, medRxiv, DOI [10.1101/2020.08.28.20184010, 10.1101/2020.08.28.20184010v1, DOI 10.1101/2020.08.28.20184010V1]
  10. Caramelli B, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.05001
  11. Chiste JA, 2021, J PERINAT MED, V49, P717, DOI 10.1515/jpm-2021-0173
  12. Cleto-Yamane TL, 2021, EUR J PEDIATR, V180, P3237, DOI 10.1007/s00431-021-04044-9
  13. Costa SF, 2020, RES SQUARE
  14. Costa SF, 2021, CLIN INFECT DIS, V73, pE1214, DOI 10.1093/cid/ciaa1845
  15. Couto AC, 2021, PLOS NEGL TROP DIS, V15
  16. Cristelli MP, 2021, TRANSPL INFECT DIS, V23, DOI 10.1111/tid.13706
  17. Vieira MADES, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0351-2020
  18. da Silva HP, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11696-7
  19. Oliveira LMD, 2020, REV INST MED TROP SP, V62, DOI [10.1590/S1678-9946202062091, 10.1590/s1678-9946202062091]
  20. de Barros ENC, 2021, REV INST MED TROP SP, V63, DOI [10.1590/S1678-9946202163010, 10.1590/s1678-9946202163010]
  21. de Oliveira MS, 2021, AM J INFECT CONTROL, V49, P1197, DOI 10.1016/j.ajic.2021.03.010
  22. Araujo AAD, 2021, EPIDEMIOL INFECT, V149, DOI 10.1017/S0950268821001163
  23. Araujo AAD, 2021, EXCLI J, V20, P276, DOI 10.17179/excli2021-3459
  24. Diegoli H, 2021, medRxiv, DOI [10.1101/2021.02.08.21251009, 10.1101/2021.02.08.21251009, DOI 10.1101/2021.02.08.21251009]
  25. Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
  26. Faria NR, 2021, SCIENCE, V372, P815, DOI [10.1101/2021.02.26.21252554, 10.1126/science.abh2644, 10.1126/science.abh2644Article]
  27. Fundacao Municipal de Saude Prefeitura de Teresina, PESQ INV SOR
  28. Garibaldi PMM, 2021, BRAZ J INFECT DIS, V25, DOI 10.1016/j.bjid.2021.101570
  29. Gomes CC, 2020, medRxiv, DOI [10.1101/2020.06.13.20130559, 10.1101/2020.06.13.20130559, DOI 10.1101/2020.06.13.20130559]
  30. Gurgel RQ, 2021, J INFECTION, V82, P206, DOI 10.1016/j.jinf.2020.11.037
  31. Hallal PC, 2021, AM J PUBLIC HEALTH, V111, P1542, DOI 10.2105/AJPH.2021.306351
  32. Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427
  33. Horta Bernardo L, 2020, Rev Panam Salud Publica, V44, pe135, DOI 10.26633/RPSP.2020.135
  34. Ismael C., 2020, PREPRINT
  35. Jones JM, 2021, JAMA-J AM MED ASSOC, V326, P1400, DOI 10.1001/jama.2021.15161
  36. Lalwani P, 2021, INT J INFECT DIS, V110, P141, DOI 10.1016/j.ijid.2021.07.017
  37. Lugon P, 2021, PEDIATRICS, V148, DOI 10.1542/peds.2021-050182
  38. Maciel Ethel Leonor Noia, 2021, Rev. bras. epidemiol., V24, pe210048, DOI 10.1590/1980-549720210048
  39. Martinez EZ, 2021, REV SOC BRAS MED TRO, V54
  40. Melo MSD, 2020, medRxiv, DOI [10.1101/2020.09.24.20200873, 10.1101/2020.09.24.20200873, DOI 10.1101/2020.09.24.20200873]
  41. Miraglia JL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255412
  42. Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1136/bmj.b2535, 10.1186/s13643-015-0087-2, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299]
  43. da Silva AAM, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054003278
  44. Murhekar MV, 2021, INT J INFECT DIS, V108, P145, DOI 10.1016/j.ijid.2021.05.040
  45. Nicolete VC, 2021, CLIN INFECT DIS, V73, P2045, DOI 10.1093/cid/ciab410
  46. Pasqualotto AC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249672
  47. Paula CC, 2020, PREPRINT, DOI [10.1101/202010:26.20219683, DOI 10.1101/202010:26.20219683]
  48. Picon RV, 2020, INT J INFECT DIS, V100, P402, DOI 10.1016/j.ijid.2020.09.028
  49. Pinto VC, 2021, INT J INFECT DIS, V108, P20, DOI 10.1016/j.ijid.2021.04.086
  50. Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5
  51. Pontes GS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96843-1
  52. Rodrigues EPS, 2021, INT J EQUITY HEALTH, V20, DOI 10.1186/s12939-021-01392-8
  53. Sales MJT, 2020, PREPRINT, DOI [10.1101/2020.10.2220216010, DOI 10.1101/2020.10.2220216010]
  54. Santana FM, 2020, RES SQUARE, DOI [10.21203/rs.3.rs-97191/v1, DOI 10.21203/RS.3.RS-97191/V1]
  55. Secretaria de Estado da Saude do Espirito Santo, COR INQ SOR
  56. Secretaria Executiva de Vigilancia em Saude do Ceara, SOR COVID 19
  57. Secretaria Municipal de Saude da Prefeitura da Cidade do Rio de Janeiro, PAIN INQ SOR COVID 1
  58. Secretaria Municipal de Saude da Prefeitura de Campinas, INQ SOR CAMP COVID 1
  59. Secretaria Municipal de Saude da Prefeitura de Sao Paulo, FASES 1 4 PREV INF E
  60. Silva VO, 2020, medRxiv, DOI [10.1101/2020.10.19.20213421, 10.1101/2020.10.19.20213421, DOI 10.1101/2020.10.19.20213421]
  61. SoroEpi MSP, SER SOR SURV MON PRE
  62. Stringari LL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244937
  63. Tess BH, 2021, BRAZ J INFECT DIS, V25, DOI 10.1016/j.bjid.2021.101604
  64. Trafane Luiza Francisco, 2021, EJHaem, V2, P478, DOI 10.1002/jha2.254
  65. Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPR
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - LIM/38
Artigos e Materiais de Revistas Científicas - LIM/47
Artigos e Materiais de Revistas Científicas - ODS/03